Two sides of the same coin: Non-alcoholic fatty liver disease and atherosclerosis
Article in Vascular Pharmacology (December 2023)
The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.
Fenofibrate improves hepatic steatosis, insulin resistance, and shapes the gut microbiome via TFEB-autophagy in NAFLD mice
Article in European Journal of Pharmacology (October 2023)
Molecular mechanisms of metabolic associated fatty liver disease (MAFLD): functional analysis of lipid metabolism pathways
Article in Clinical Science (September 2022)